{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:43:48Z","timestamp":1770291828542,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ad.2017.06.021","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T23:37:27Z","timestamp":1513208247000},"page":"312-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Morfea en la infancia: actualizaci\u00f3n"],"prefix":"10.1016","volume":"109","author":[{"given":"B.","family":"Aranegui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jim\u00e9nez-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2017.06.021_bib0360","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","article-title":"Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland","volume":"62","author":"Herrick","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.ad.2017.06.021_bib0365","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0370","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ad.2017.06.021_bib0375","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0380","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1365-2133.2011.10600.x","article-title":"Misdiagnosis and delay in referral of children with localized scleroderma","volume":"165","author":"Weibel","year":"2011","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0385","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/bjd.12606","article-title":"Short- and long-term outcome of linear morphoea in children","volume":"169","author":"Piram","year":"2013","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0390","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk","year":"2003","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0395","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0400","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/BOR.0b013e3283641f61","article-title":"Scleroderma in children: an update","volume":"25","author":"Zulian","year":"2013","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0405","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaad.2010.02.065","article-title":"Clinicohistopathological correlations in juvenile localized scleroderma: studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes","volume":"65","author":"Sung","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0410","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.ad.2017.06.021_bib0415","series-title":"Proceedings of the II Workshop on nomenclature and diagnostic criteria for Juvenile Scleroderma Syndromes; 3-6 June 2004; Padua","first-page":"5","article-title":"Preliminary classification criteria for juvenile systemic sclerosis","author":"Zulian","year":"2005"},{"key":"10.1016\/j.ad.2017.06.021_bib0420","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0425","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-104-6-849","article-title":"Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities","volume":"104","author":"Falanga","year":"1986","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.ad.2017.06.021_bib0430","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaad.2005.10.020","article-title":"Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients","volume":"54","author":"Sommer","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0435","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1525-1470.2007.00363.x","article-title":"Linear morphea presenting as acquired unilateral edema","volume":"24","author":"Fiala","year":"2007","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0440","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.rdc.2007.11.004","article-title":"Systemic sclerosis and localized scleroderma in childhood","volume":"34","author":"Zulian","year":"2008","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.ad.2017.06.021_bib0445","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea: part II. Outcome measures and treatment","volume":"64","author":"Fett","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0450","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/rheumatology\/keu212","article-title":"United Kingdom survey of current management of juvenile localized scleroderma","volume":"53","author":"Hawley","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ad.2017.06.021_bib0455","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","article-title":"A systematic review of morphea treatments and therapeutic algorithm","volume":"65","author":"Zwischenberger","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0460","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","article-title":"Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea","volume":"18","author":"Kreuter","year":"2001","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0465","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter","year":"2006","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0470","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2008.12.013","article-title":"Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment","volume":"60","author":"Sator","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0475","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1996.03890350014001","article-title":"PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients","volume":"132","author":"Kerscher","year":"1996","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0480","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2133.1995.tb00738.x","article-title":"PUVA therapy in disabling pansclerotic morphoea of children","volume":"132","author":"Scharffetter-Kochanek","year":"1995","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0485","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2133.1998.02060.x","article-title":"PUVA therapy for disabling pansclerotic morphoea of children","volume":"138","author":"Todd","year":"1998","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0490","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1346-8138.2003.tb00446.x","article-title":"Pansclerotic morphea treated with UVA: a case report","volume":"30","author":"Yildirim","year":"2003","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0495","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1525-1470.1999.99016.x","article-title":"Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children","volume":"16","author":"Elst","year":"1999","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0500","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mjd.2000.108369","article-title":"Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma","volume":"43","author":"Hulshof","year":"2000","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0505","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2133.2004.06318.x","article-title":"Localized scleroderma: response to occlusive treatment with tacrolimus ointment","volume":"152","author":"Mancuso","year":"2005","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0510","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1346-8138.2008.00552.x","article-title":"Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study","volume":"35","author":"Stefanaki","year":"2008","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0515","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000335560","article-title":"Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study","volume":"223","author":"Pope","year":"2011","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2017.06.021_bib0520","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children","volume":"155","author":"Weibel","year":"2006","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0525","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ad.2017.06.021_bib0530","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archderm.141.7.847","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma","volume":"141","author":"Kreuter","year":"2005","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0535","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J Pediatr."},{"key":"10.1016\/j.ad.2017.06.021_bib0540","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0545","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini","year":"2009","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ad.2017.06.021_bib0550","first-page":"2538","article-title":"Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children","volume":"33","author":"Roldan","year":"2006","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0555","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00105-006-1277-6","article-title":"Surgical correction of scleroderma en coup de sabre","volume":"58","author":"Dirschka","year":"2007","journal-title":"Hautarzt."},{"key":"10.1016\/j.ad.2017.06.021_bib0560","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1203475415624912","article-title":"Treatment of Linear Scleroderma (en Coup de Sabre) With Dermal Fat Grafting","volume":"20","author":"Barin","year":"2016","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.ad.2017.06.021_bib0565","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.bjps.2007.12.019","article-title":"Correction of facial linear scleroderma \u2018coup de sabre\u2019 with BoneSource","volume":"62","author":"Hwang","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"10.1016\/j.ad.2017.06.021_bib0570","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jdv.13790","article-title":"A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients","volume":"31","author":"Lis-Swiety","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"2 Pt 1","key":"10.1016\/j.ad.2017.06.021_bib0575","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(98)70079-9","article-title":"Low-dose methotrexate in the treatment of widespread morphea","volume":"39","author":"Seyger","year":"1998","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0580","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0190-9622(97)70121-X","article-title":"Reliability of two methods to assess morphea: skin scoring and the use of a durometer","volume":"37","author":"Seyger","year":"1997","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0585","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/14397595.2013.844301","article-title":"High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma","volume":"24","author":"Porta","year":"2014","journal-title":"Mod Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0590","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kel446","article-title":"A new computerized method for the assessment of skin lesions in localized scleroderma","volume":"46","author":"Zulian","year":"2007","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ad.2017.06.021_bib0595","first-page":"650","article-title":"Localized scleroderma severity index and global assessments: a pilot study of outcome instruments","volume":"35","author":"Arkachaisri","year":"2008","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0600","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3899\/jrheum.081284","article-title":"The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures","volume":"36","author":"Arkachaisri","year":"2009","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0605","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/kep361","article-title":"Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study","volume":"49","author":"Arkachaisri","year":"2010","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ad.2017.06.021_bib0610","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.ad.2017.06.021_bib0615","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","article-title":"The localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical population","volume":"69","author":"Kelsey","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0620","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","article-title":"First case series on the use of imiquimod for morphoea","volume":"153","author":"Dytoc","year":"2005","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0625","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2310\/7750.2014.14072","article-title":"Evaluation of the efficacy and safety of topical imiquimod 5% for plaque-type morphea: a multicenter, prospective, vehicle-controlled trial","volume":"19","author":"Dytoc","year":"2015","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.ad.2017.06.021_bib0630","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/bjd.14001","article-title":"Correlation of clinical tools to determine activity of localized scleroderma in paediatric patients","volume":"174","author":"Garcia-Romero","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0635","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3899\/jrheum.100447","article-title":"Influence of childhood scleroderma on physical function and quality of life","volume":"38","author":"Baildam","year":"2011","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0640","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","article-title":"Low-dose UVA phototherapy for treatment of localized scleroderma","volume":"38","author":"Kerscher","year":"1998","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0645","first-page":"167","article-title":"Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma","volume":"38","author":"Li","year":"2011","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0650","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaad.2009.06.016","article-title":"Clinical usefulness of variable-frequency ultrasound in localized lesions of the skin","volume":"62","author":"Wortsman","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0655","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jaad.2010.08.027","article-title":"Activity assessment in morphea using color Doppler ultrasound","volume":"65","author":"Wortsman","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0660","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0846.2009.00371.x","article-title":"Validation of a protocol for the assessment of skin temperature and blood flow in childhood localised scleroderma","volume":"15","author":"Howell","year":"2009","journal-title":"Skin Res Technol."},{"key":"10.1016\/j.ad.2017.06.021_bib0665","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1002\/art.22920","article-title":"Laser Doppler flowmetry for assessing localized scleroderma in children","volume":"56","author":"Weibel","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ad.2017.06.021_bib0670","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/41.10.1178","article-title":"Juvenile-onset localized scleroderma activity detection by infrared thermography","volume":"41","author":"Martini","year":"2002","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ad.2017.06.021_bib0675","first-page":"968","article-title":"Childhood linear scleroderma: a possible role of thermography for evaluation","volume":"19","author":"Birdi","year":"1992","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0680","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2214\/AJR.07.2163","article-title":"MRI findings in deep and generalized morphea (localized scleroderma)","volume":"190","author":"Horger","year":"2008","journal-title":"AJR Am J Roentgenol."},{"key":"10.1016\/j.ad.2017.06.021_bib0685","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiol.11102136","article-title":"Localized scleroderma: MR findings and clinical features","volume":"260","author":"Schanz","year":"2011","journal-title":"Radiology."},{"key":"10.1016\/j.ad.2017.06.021_bib0690","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.2009.09438.x","article-title":"Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study","volume":"162","author":"Andres","year":"2010","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0695","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000073093","article-title":"Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method","volume":"207","author":"de Rie","year":"2003","journal-title":"Dermatology."},{"key":"10.1016\/j.ad.2017.06.021_bib0700","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/bjd.14103","article-title":"Durometry as an outcome measure in juvenile localized scleroderma","volume":"174","author":"Poff","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0705","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.2011.10535.x","article-title":"Relapse after systemic treatment in paediatric morphoea","volume":"166","author":"Mirsky","year":"2012","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2017.06.021_bib0710","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","article-title":"An evaluation of long-term outcomes in adults with pediatric-onset morphea","volume":"146","author":"Saxton-Daniels","year":"2010","journal-title":"Arch Dermatol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017305872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017305872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:07:57Z","timestamp":1757552877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731017305872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0001731017305872"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2017.06.021","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morfea en la infancia: actualizaci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2017.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}